A carregar...
Stratification of responders towards eculizumab using a structural epitope mapping strategy
The complement component 5 (C5)-binding antibody eculizumab is used to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical haemolytic uremic syndrome (aHUS). As recently reported there is a need for a precise classification of eculizumab responsive patients to allow for a safe...
Na minha lista:
| Publicado no: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4980765/ https://ncbi.nlm.nih.gov/pubmed/27509843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep31365 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|